Martin Kerr

Martin Kerr has a strong background in scientific research and business development within the pharmaceutical industry. Currently, Martin is focused on building partnerships with pharma and biotech companies to enhance drug discovery using explainable AI at Abzu. Prior to this role, Martin held positions at NATA, MRC Laboratory of Molecular Biology, and the University of Oxford where Martin developed strategic partnerships with pharma and biotech organizations. Martin has also worked on projects related to oligonucleotide drug design, disease understanding through multi-omic analyses, and Epithelial Growth Factor signaling in Drosophila development.